Study participants
Our unit is a metropolitan tertiary neonatal unit. All neonates prescribed their first course of systemic dexamethasone to aid in extubation from mechanical ventilation with evidence of BPD, who were born at <30 weeks GA between January 2007 to December 2017 and admitted to the GSNU, were eligible to be included in the retrospective cohort study. The timing and dose of dexamethasone was determined by the neonate’s treating neonatologist. The treatment plan was chosen from a range of dexamethasone dosing regimens. Neonates who received dexamethasone were identified using the NeoDATA database.
Inclusion criteria:
Exclusion criteria
This study was considered exempt from full ethical review by the Royal Brisbane and Women’s Hospital Human Research Ethics Committee with no requirement for parental informed consent given the retrospective, de-identified data collected.